Sanofi SAN.PA Stock
Sanofi Price Chart
Sanofi SAN.PA Financial and Trading Overview
Sanofi stock price | 104.26 EUR |
Previous Close | 94.26 EUR |
Open | 94.98 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 94.78 - 95.37 EUR |
52 Week Range | 76.45 - 105.18 EUR |
Volume | 114.14K EUR |
Avg. Volume | 1.71M EUR |
Market Cap | 120.84B EUR |
Beta (5Y Monthly) | 0.416091 |
PE Ratio (TTM) | 14.327819 |
EPS (TTM) | 4.54 EUR |
Forward Dividend & Yield | 3.56 (3.79%) |
Ex-Dividend Date | May 30, 2023 |
1y Target Est | 107.1 EUR |
SAN.PA Valuation Measures
Enterprise Value | 126.19B EUR |
Trailing P/E | 14.327819 |
Forward P/E | 10.693603 |
PEG Ratio (5 yr expected) | 1.5 |
Price/Sales (ttm) | 2.6156573 |
Price/Book (mrq) | 1.5959531 |
Enterprise Value/Revenue | 2.731 |
Enterprise Value/EBITDA | 8.767 |
Trading Information
Sanofi Stock Price History
Beta (5Y Monthly) | 0.416091 |
52-Week Change | 0.095% |
S&P500 52-Week Change | 20.43% |
52 Week High | 105.18 EUR |
52 Week Low | 76.45 EUR |
50-Day Moving Average | 99.42 EUR |
200-Day Moving Average | 90.09 EUR |
SAN.PA Share Statistics
Avg. Volume (3 month) | 1.71M EUR |
Avg. Daily Volume (10-Days) | 1.37M EUR |
Shares Outstanding | 1.25B |
Float | 1.1B |
Short Ratio | N/A |
% Held by Insiders | 11.39% |
% Held by Institutions | 43.73% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | 376.00% |
Payout Ratio | 0.5008 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 18.08% |
Operating Margin (ttm) | 24.42% |
Gross Margin | 69.93% |
EBITDA Margin | 31.15% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 46.2B EUR |
Revenue Per Share (ttm) | 36.9 EUR |
Quarterly Revenue Growth (yoy) | 8.09% |
Gross Profit (ttm) | 31.7B EUR |
EBITDA | 14.39B EUR |
Net Income Avi to Common (ttm) | 8.36B EUR |
Diluted EPS (ttm) | 6.65 |
Quarterly Earnings Growth (yoy) | -0.70% |
Balance Sheet
Total Cash (mrq) | 12.74B EUR |
Total Cash Per Share (mrq) | 10.2 EUR |
Total Debt (mrq) | 21.21B EUR |
Total Debt/Equity (mrq) | 28.23 EUR |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 59.701 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Sanofi
Country | France |
State | N/A |
City | Paris |
Address | 46, avenue de la Grande Arm e |
ZIP | 75017 |
Phone | 33 1 53 77 40 00 |
Website | https://www.sanofi.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 91573 |
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Q&A For Sanofi Stock
What is a current SAN.PA stock price?
Sanofi SAN.PA stock price today per share is 104.26 EUR.
How to purchase Sanofi stock?
You can buy SAN.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sanofi?
The stock symbol or ticker of Sanofi is SAN.PA.
Which industry does the Sanofi company belong to?
The Sanofi industry is Drug Manufacturers-General.
How many shares does Sanofi have in circulation?
The max supply of Sanofi shares is 1.26B.
What is Sanofi Price to Earnings Ratio (PE Ratio)?
Sanofi PE Ratio is 22.96475800 now.
What was Sanofi earnings per share over the trailing 12 months (TTM)?
Sanofi EPS is 4.54 EUR over the trailing 12 months.
Which sector does the Sanofi company belong to?
The Sanofi sector is Healthcare.
Sanofi SAN.PA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
CAC 40 FCHI | 8030.68 EUR 8778.62 USD |
+0.02
|
— — | 7984.72 EUR 8728.38 USD | 8067.07 EUR 8818.4 USD | — - | — — |
SBF 120 SBF120 | 6071.34 EUR 6636.79 USD |
+0.19
|
— — | 6027.36 EUR 6588.72 USD | 6087.06 EUR 6653.98 USD | — - | — — |
Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
Euronext 100 Index N100 | 1571.48 EUR 1717.84 USD |
+0.08
|
— — | 1564.76 EUR 1710.49 USD | 1575.75 EUR 1722.51 USD | — - | — — |
EURO STOXX 50 I STOXX50E | 5395.49 EUR 5898 USD |
+0.08
|
— — | 5366 EUR 5865.76 USD | 5414.14 EUR 5918.39 USD | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
- {{ link.label }} {{link}}